发明申请
- 专利标题： LONG ACTING FORMULATION OF BIOPHARMACEUTICAL
- 专利标题（中）： 生物医学的长期制定
-
申请号： US12422950申请日： 2009-04-13
-
公开(公告)号： US20100261245A1公开(公告)日： 2010-10-14
- 发明人: Sei-Kwang HAHN , Hyun-Gu Kang , Sung-Ho Ryu , Jung-Kyu Park , Eun-Ju Oh
- 申请人： Sei-Kwang HAHN , Hyun-Gu Kang , Sung-Ho Ryu , Jung-Kyu Park , Eun-Ju Oh
- 主分类号： C12N9/00
- IPC分类号： C12N9/00 ; C07D207/40 ; C07K14/00 ; C07H21/00 ; C07H1/00
摘要：
The invention relates to a long-acting formulation of biopharmaceutical, more specifically an aptamer therapeutics. A branched PEGylated aptamer or a hyaluronic acid (HA) derivative of which degradation in vivo is regulated is linked by the bioconjugation with biopharmaceutical to produce the long-action formulation.
公开/授权文献
- US08247493B2 Long acting formulation of biopharmaceutical 公开/授权日：2012-08-21
信息查询
